The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).
NCT00361946 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2017-04-24
Summary
To study postprandial metabolism in lean, obese and T2DM adolescents using a mixed meal challenge. Specifically we will be measuring the following parameters of postprandial metabolism: 1. Postprandial glucose and triglycerides excursions 2. Gastric emptying 3. Insulin, amylin, glucagon, GLP-1 and ghrelin secretion 4. Glucose Turnover rate
Conditions
Sponsors & Collaborators
-
Baylor College of Medicine
lead OTHER
Principal Investigators
-
Luisa M Rodriguez, MD · Baylor College of Medicine
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
Countries
- United States
Study Locations
More Related Trials
-
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
NCT01449019 ·Status: COMPLETED ·Phase: PHASE1
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
NCT05177653 ·Status: COMPLETED ·Phase: NA
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus
NCT01663220 ·Status: COMPLETED
-
The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion
NCT01656057 ·Status: COMPLETED ·Phase: NA
-
The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic Hyperglucagonemia
NCT00639613 ·Status: COMPLETED
-
Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients
NCT01374594 ·Status: COMPLETED
-
The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
NCT00950677 ·Status: COMPLETED ·Phase: PHASE4
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus
NCT00445627 ·Status: COMPLETED
-
Hyperglycemia and the Extra-pancreatic Effect of Incretins
NCT01749163 ·Status: COMPLETED ·Phase: NA
-
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
NCT04177303 ·Status: UNKNOWN ·Phase: PHASE3
-
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
NCT00832741 ·Status: COMPLETED
-
Incretins and Metabolism
NCT01607944 ·Status: COMPLETED
-
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NCT06173934 ·Status: RECRUITING ·Phase: NA
-
Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.
NCT00537719 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide
NCT00489645 ·Status: COMPLETED ·Phase: NA
-
Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.
NCT01232244 ·Status: COMPLETED
-
The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
NCT00845559 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction
NCT03129594 ·Status: COMPLETED
-
Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
NCT01663207 ·Status: COMPLETED
-
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
NCT03195400 ·Status: COMPLETED
-
Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus
NCT00655603 ·Status: UNKNOWN ·Phase: NA